{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:47:59Z","timestamp":1768312079345,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-I2M-1-063"],"award-info":[{"award-number":["2021-I2M-1-063"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The aim of this study was to investigate the outcomes of catheter ablation (CA) in preventing arrhythmic events among patients with symptomatic Brugada syndrome (BrS) who declined implantable cardioverter defibrillator (ICD) implantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A total of 40 patients with symptomatic BrS were included in the study, of which 18 refused ICD implantation and underwent CA, while 22 patients received ICD implantation. The study employed substrate modification (including endocardial and epicardial approaches) and ventricular fibrillation (VF)-triggering pre-mature ventricular contraction (PVC) ablation strategies. The primary outcomes were a composite endpoint consisting of episodes of VF and sudden cardiac death during the follow-up period. The study population had a mean age of 43.8 \u00b1 9.6 years, with 36 (90.0%) of them being male. All patients exhibited the typical Type 1 BrS electrocardiogram pattern, and 16 (40.0%) were carriers of an SCN5A mutation. The Shanghai risk scores were comparable between the CA and the ICD groups (7.05 \u00b1 0.80 vs. 6.71 \u00b1 0.86, P = 0.351). Ventricular fibrillation\u2013triggering PVCs were ablated in 3 patients (16.7%), while VF substrates were ablated in 15 patients (83.3%). Epicardial ablation was performed in 12 patients (66.7%). During a median follow-up of 46.2 (17.5\u201373.7) months, the primary outcomes occurred more frequently in the ICD group than in the CA group (5.6 vs. 54.5%, Log-rank P = 0.012).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Catheter ablation is an effective alternative therapy for improving arrhythmic outcomes in patients with symptomatic BrS who decline ICD implantation. Our findings support the consideration of CA as an alternative treatment option in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad318","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T05:17:43Z","timestamp":1698297463000},"source":"Crossref","is-referenced-by-count":14,"title":["Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-8480","authenticated-orcid":false,"given":"Le","family":"Li","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligang","family":"Ding","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmin","family":"Wu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2867-411X","authenticated-orcid":false,"given":"Lihui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1501-2209","authenticated-orcid":false,"given":"Zhenhao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-6405","authenticated-orcid":false,"given":"Yulong","family":"Xiong","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-6610","authenticated-orcid":false,"given":"Zhuxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-4323","authenticated-orcid":false,"given":"Yan","family":"Yao","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital , Beilishi Road 167#, Xicheng District, Beijing 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2024100409361095600_euad318-B1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/eurheartj\/ehx490","article-title":"The definition of the Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"2024100409361095600_euad318-B2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","article-title":"Present status of Brugada syndrome: JACC state-of-the-art review","volume":"72","author":"Brugada","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024100409361095600_euad318-B5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B6","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2024100409361095600_euad318-B7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2017.10.082","article-title":"Implantable cardioverter-defibrillators in children and adolescents with Brugada syndrome","volume":"71","author":"Gonzalez Corcia","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.joa.2015.12.008","article-title":"Alternative approach for management of an electrical storm in Brugada syndrome: importance of primary ablation within a narrow time window","volume":"32","author":"Talib","year":"2016","journal-title":"J Arrhythm"},{"key":"2024100409361095600_euad318-B9","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1540-8167.2012.02433.x","article-title":"Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome","volume":"23","author":"Sunsaneewitayakul","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024100409361095600_euad318-B10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024100409361095600_euad318-B11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.hrthm.2016.07.025","article-title":"Characterization of the epicardial substrate for catheter ablation of Brugada syndrome","volume":"13","author":"Zhang","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024100409361095600_euad318-B12","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024100409361095600_euad318-B13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.122.063367","article-title":"Long-term outcomes of Brugada substrate ablation: a report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)","volume":"147","author":"Nademanee","year":"2023","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B14","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","article-title":"Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome","volume":"42","author":"Probst","year":"2021","journal-title":"Eur Heart J"},{"key":"2024100409361095600_euad318-B15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B16","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jacc.2010.06.050","article-title":"Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: detection of type 1 electrocardiogram in the right ventricular outflow tract","volume":"56","author":"Nagase","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacep.2018.02.009","article-title":"Shanghai score system for diagnosis of Brugada syndrome: validation of the score system and system and reclassification of the patients","volume":"4","author":"Kawada","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2024100409361095600_euad318-B18","doi-asserted-by":"crossref","first-page":"euad091","DOI":"10.1093\/europace\/euad091","article-title":"Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects","volume":"25","author":"Konemann","year":"2023","journal-title":"Europace"},{"key":"2024100409361095600_euad318-B19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/europace\/euaa223","article-title":"Diagnosis, family screening, and treatment of inherited arrhythmogenic diseases in Europe: results of the European Heart Rhythm Association survey","volume":"22","author":"Conte","year":"2020","journal-title":"Europace"},{"key":"2024100409361095600_euad318-B20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/europace\/euq282","article-title":"European utilization of the implantable defibrillator: has 10 years changed the \u2018enigma\u2019?","volume":"12","author":"John Camm","year":"2010","journal-title":"Europace"},{"key":"2024100409361095600_euad318-B21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.hrthm.2014.02.019","article-title":"Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region","volume":"11","author":"Hoang","year":"2014","journal-title":"Heart Rhythm"},{"key":"2024100409361095600_euad318-B22","doi-asserted-by":"crossref","first-page":"e003651","DOI":"10.1161\/CIRCOUTCOMES.116.003651","article-title":"Disparity between indications for and utilization of implantable cardioverter defibrillators in Asian patients with heart failure","volume":"10","author":"Chia","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2024100409361095600_euad318-B23","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B24","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/CIRCULATIONAHA.105.532614","article-title":"Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study","volume":"112","author":"Coronel","year":"2005","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCULATIONAHA.118.035954","article-title":"Beyond the one gene-one disease paradigm: complex genetics and pleiotropy in inheritable cardiac disorders","volume":"140","author":"Cerrone","year":"2019","journal-title":"Circulation"},{"key":"2024100409361095600_euad318-B26","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/cvr\/cvab213","article-title":"Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology","volume":"118","author":"Chaumont","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024100409361095600_euad318-B28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCEP.114.002420","article-title":"Role of high-resolution image integration to visualize left phrenic nerve and coronary arteries during epicardial ventricular tachycardia ablation","volume":"8","author":"Yamashita","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024100409361095600_euad318-B29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2010.04.054","article-title":"Effect of epicardial fat on electroanatomical mapping and epicardial catheter ablation","volume":"56","author":"Desjardins","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2024100409361095600_euad318-B30","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.hrthm.2021.06.1188","article-title":"Role of endocardial ablation in eliminating an epicardial arrhythmogenic substrate in patients with Brugada syndrome","volume":"18","author":"Kamakura","year":"2021","journal-title":"Heart Rhythm"},{"key":"2024100409361095600_euad318-B31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","article-title":"Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review","volume":"15","author":"Fernandes","year":"2018","journal-title":"Heart Rhythm"},{"key":"2024100409361095600_euad318-B32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2017.01.006","article-title":"A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome","volume":"14","author":"Chung","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024100409361095600_euad318-B33","doi-asserted-by":"crossref","first-page":"e005631","DOI":"10.1161\/CIRCEP.117.005631","article-title":"Efficacy of endocardial ablation of drug-resistant ventricular fibrillation in Brugada syndrome: long-term outcome","volume":"11","author":"Talib","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024100409361095600_euad318-B34","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0735-1097(00)00932-3","article-title":"Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy","volume":"36","author":"Kakishita","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euad318\/52633111\/euad318.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/1\/euad318\/59587186\/euad318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/1\/euad318\/59587186\/euad318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T09:36:39Z","timestamp":1728034599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad318\/7330978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad318","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,10,27]]},"article-number":"euad318"}}